Annexon, Inc.(ANNX)股价今日盘中出现大幅下跌,跌幅达到5.31%。这一下跌引发了市场的广泛关注。
消息面上,分析师机构摩根大通将该公司目标价从11美元下调至9美元。这一调低目标价的行为,引发了市场对公司前景的担忧,导致投资者纷纷抛售该股股票,从而引发了股价的大幅下挫。
Annexon, Inc.是一家生物制药公司,专注于开发新型治疗经典补体介导疾病药物。虽然目前公司尚无营收,但其产品线备受市场关注。分析师下调目标价或将加剧投资者对公司前景的担忧,这可能是推动今日股价下跌的主要原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.